|
Biotech: doing VERY well with Vertex Pharmaceuticals (NASDAQ:VRTX). Today up about 2.75. Steady growth. One on the most difficult medical conditions to treat is CF (Cystic Fibrosis) Vertex has a very healthy marketing cap of 42 billion in a sector that is clogged will slow movers.
|